SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,771.72 -1,124.02
( -1.52%)

Global Indices

Nasdaq

51,839.66 468.68
(0.91%)

Dow Jones

7,763.25 38.12
(0.49%)

Hang Seng

66,234.37 -129.83
(-0.20%)

Nikkei 225

10,694.57 14.58
(0.14%)

Forex

USD-INR

95.89 0.16
(0.16%)

EUR-INR

109.08 -0.12
(-0.11%)

GBP-INR

126.82 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Wanbury update on filing of DFM in US and South Korea

Jul 30,2026

Wanbury recently received “No DMF deficiency letter” from the office of USFDA (US Food and Drug Administration) for multiple ANDAs (Abbreviated New Drug Applications) with Metformin HCl API source of Wanbury for different formulations.

Further, Wanbury expanded business opportunities in South Korea for one more API by filing the DMF. Wanbury is committed for supply of best APIs to the new market for well-being of human being.

72,771.72 -1,124.02 ( -1.52%)

51,839.66 468.68 (0.91%)

7,763.25 38.12 (0.49%)

66,234.37 -129.83 (-0.20%)

10,694.57 14.58 (0.14%)

95.89 0.16 (0.16%)

109.08 -0.12 (-0.11%)

126.82 -0.30 (-0.24%)

0.60 0.00 (-0.20%)